The ssim3p3 function simulates n dose-escalation study with the 3+3 design and provides summarized results.
ssim3p3(truerate, n, r = 2, seed = NULL)
A nlevel-length vector of true rates for the DLTs.
Number of studies to simulate.
Integer, number of digits for percentages in output.
If not empty, the seed to use for random generation.
Summarized result in a "np1" view.
Percentage of studies with no recommendation for the MTD (in case of the first level is considered as toxic).
Mean number of enrolled patients.
Mean number of observed DLTs.
Mean last experimented dose level.
O'Quigley J., Pepe M., Fisher L. (1990). Continual Reassessment Method: a practical design for Phase I clinical trials in cancer. Biometrics 46, 33-48.
O'Quigley J., Shen LZ. (1996). Continual Reassessment Method: a likelihood approach. Biometrics 52, 673-684.
Paoletti X., Kramar A. (2009). A comparison of model choices for the Continual Reassessment Method in phase I cancer trials. Statistics in Medecine 28, 3012-3028.
Chamorey Emmanuel. (2009). Methodologie des essais de phase precoce en cancerologie: evolution des schemas et apport de la pharmacologie. These.
Garret-Mayer Elizabeth. (2006). The Continual Reassessment Method for dose-finding studies: a tutorial. Clinical Trials: 57-71.
# NOT RUN {
ssim3p3(c(0.1,0.2,0.25,0.35),100)
# }
Run the code above in your browser using DataLab